Roche's product deal flow

Roche's product deal flow

Date Partner Disease area Status at time of deal Deal
4/9/02 Isotechnika (TSE:ISA) Autoimmune/Inflammation, Transplant Ph II Will co-develop ISA's ISA247, a calcineurin inhibitor immunosuppressant in Phase

Read the full 314 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE